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This study was designed to investigate the eﬀect of pulse width modulation electro-acupuncture (PWM-EA) on cardiovascular
remodeling and nitric oxide (NO) in spontaneously hypertensive rats (SHR). Thirty-four male SHR were randomly divided into
control, captopril, and two PWM-EA groups, which were treated with 350Hz (SHR-350Hz) and whole audio bandwith electro-
acupuncture (SHR-WAB group) respectively, on the ST 36 point located on the outside of the hind leg. Systolic blood pressure
(BP), plasma and myocardial NO were measured. Histological studies were also performed on the aortic wall and the left ventricle.
The BP in the SHR-350Hz, SHR-WAB and the captopril groups was lower than in the control group following the treatment (P
< .05). The average aortic media wall thickness in the two electro-acupuncture groups was less than in the control group (P <
.05). The left ventricle/heart weight ratio in the captopril and SHR-350Hz groups was less than in the control group (P < .01), but
was similar between the SHR-WAB and the control group (P > .05). The plasma and myocardium NO levels were elevated in the
captopril and the SHR-350Hz group (P < .05 and .01, resp.). The plasma level of NO in the SHR-WAB group was also higher than
in the control group (P < .05). We concluded that pulse width modulation electro-acupuncture on the ST 36 point prevents the
progression of hypertension and diminishes the cardiovascular remodeling in SHR. It also elevates plasma and cardiac NO in this
animal model.
1.Introduction
Left ventricular (LV) hypertrophy and vascular remodeling
are the two common pathological ﬁndings in patients
with hypertension. Prevention and reversal of LV hyper-
trophy and vascular remodeling are some of the major
therapeutic objectives for hypertension management. Non-
pharmacological treatment of hypertension is an important
part of the therapeutic strategy. Acupuncture is one such
strategy, although some have claimed that the supporting
evidence is equivocal [1, 2]. However, well conducted studies
have shown beneﬁt [3, 4] and it has been suggested that
methodological issues may be responsible for some of the
ambiguity [5]. Previous work has indicated that music,
acupuncture and electro-acupuncture can reduce blood
pressure (BP) and contribute to the overall management of
hypertension [4, 6, 7]. There is also evidence showing that
acupuncture or electro-acupuncture leads to improvements
in endothelial cell function, which may help with BP control
[8–10].
A major drawback with the conventional pulse electro-
acupuncture for BP control is the attenuation of the ther-
apeutic eﬀect over time [11, 12]. Musically pulsed electro-
acupuncture uses music as its output waveform signal, or
the music signal is superimposed on the periodic pulse. With
these devices, the amplitude of the output pulse varies music
amplitude, which is undesirable in the delivery of ongoing
therapy. We have developed a pulse width modulation
electro-acupuncture (PWM-EA) device for hypertension
treatment. The main feature of this unit is to regulate
the pulse duty factor of output pulses (the ratio between
the pulse duration and pulse interval), according to the2 Evidence-Based Complementary and Alternative Medicine
amplitude variation of the audio signals. The theoretical
advantage of this new device is that it avoids attenuation of
therapeutic eﬀect in the conventional acupuncture devices,
and provides stimulation at constant pulse amplitude.
Our pilot study showed that electro-acupuncture with
a pulse width modulation at 350Hz or at the whole audio
bandwidth (WAB) reduces the BP in hypertensive rats [13].
However, the eﬀect of PWM-EA on the cardiovascular
remodeling secondary to hypertension is uncertain. The
primary purpose of this study was to investigate if the
new PWM-EA would be able to diminish the ventricular
hypertrophyorvascularwallthickeninginahypertensionrat
model.Inaddition, theeﬀectofPWM-EAontheplasmaand
cardiac levels of nitric oxide (NO) was also evaluated.
2. Methods
This study was approved by the Institutional Review Board
of the Sun Yat-Sen University. All procedures were in
accordance with institutional guidelines for animal research.
Thirty-four male spontaneous hypertension rats (SHR, 13
weeks) were provided by Vital River Company (Beijing,
China). They were maintained in a quiet room at constant
temperature (20–22◦C) and humidity (50–60%) with 12-h
light–dark cycle. Systolic BP was measured in all animals by
a standard tail-cuﬀ method with sphygmomanometer. Cap-
topril was obtained from Shanghai Squibb Pharmaceuticals.
Signal processing and observation was performed with V989
VCD (Guangdong Diwa Electronic Technology, China) and
TDS2012DigitalOscilloscope(TektronixInc,USA).Weused
our own PWM-EA to treat SHR.
2.1. Animals and Treatment. The SHRs were randomly
divided into captopril (administered by gastric gav-
ages, 15.625mgkg−1 per day), the SHR-350Hz (electro-
acupuncturewithpulsewidthmodulatedby350Hz),PWM-
EA (electro-acupuncture with pulse width modulated by
whole audio-frequency), and control groups.
All treatments were administered in the mornings, once
daily for the ﬁrst ﬁve days in a week. The SHR-350Hz and
PWM-EA groups received electro-acupuncture treatment
for 30min per day. The acupuncture of both groups was
conducted in a ST 36 point (“Zusanli”), which is located
on the outside of the hind leg, just below the knee, and
outside of the tibial crest. An adhesive silver electrode patch
was attached to each side of the ST 36 points for the
delivery of the stimulation. The intensity of the electrical
stimulation was adjusted between 2–6V, to the point where
there was no noticeable muscle stimulation. After 8 weeks of
treatment, rats were euthanized with sodium pentobarbital
(2%, 1ml, IP) followed by removal of the heart and aorta for
pathological examination.
2.2. Measurement of Blood Pressure. Systolic BP was mea-
sured before the treatment and in the third, sixth, and eighth
week during the treatment in conscious SHR by an indirect
tail-cuﬀ method. The measurement was performed in the
same period of the day (morning). Rats were preheated at
30◦C for 10min, and then three consecutive measurements
of BP were averaged.
2.3. Determination of NO in Myocardium and Plasma. Blood
was collected from the right ventricle before the heart was
arrested. Two milliliters of blood was placed into a tube,
centrifuged 3000rpm for 10min. The supernatant plasma
was stored at –80◦C. After weighing the heart, 200mg
myocardialtissuewashomogenizedwith1.8mlphysiological
saline (0.86%). The homogenization was performed on
ice-bath (4◦C) and the homogenates were centrifuged at
4◦C, 3000rpm for 10min. The supernatant was stored
at –80◦C. The NO concentration was assayed with the
Greiss reagent (Nanjing Jiancheng Bioengineering Institute,
China), after reduction with nitrate reductase. The resulting
supernatant of sample mixture with medium was measured
at 550nm on a spectrophotometer (Pgeneral, T60 UV-
VIS, China). Conditioned medium from untreated samples
with no added Greiss reagent were used as sample blanks.
Known concentrations of KNO2 and KNO3 were used as
standards. All procedures were carried out according to the
manufacturer’s guide.
2.4. Tissue Preparation and Histopathology. Part of the left
ventricle and thoracic aorta were segregated, ﬁxed in 10%
formaldehyde and embedded in paraﬃn. The tissues were
sectionedin5μm,andstainedwithhematoxylin-eosin(HE).
T h eh e a r t sw e r er i n s e df o r1m i ni n0 . 0 1m o l / lc o l dP B S( p H
7.4).The weightofthe heartandtheleftventricle weredeter-
mined by electronic balance (Mettler-Toledo International
Inc, Switzerland). The heart/body and left ventricle/heart
weight ratios were calculated.
The pictures were collected by an LC evolution digital
camera of an Olympus IX-71 microscope. For the sections
of the aorta, maximal and minimal internal and external
diameters were determined at 10x magniﬁcation. These
values were used to determine the mean values of internal
and external diameters. Wall thickness was calculated by
subtraction of the two diameters. Image Prolus software
(version 5.01, Media Cybemetics, Silver Spring, USA) was
used to determine cross-sectional areas of the diﬀerent aortic
layers including the media layer. Finally, the media thickness
of the aorta was calculated as the distance from the external
elastic lamina (EEL) to the internal elastic lamina (IEL). The
cross-sectional area of the media layer is deﬁned as the result
of the EEL area minus IEL area.
2.5. Statistical Analysis. All data are presented as the mean
± SD. Two-way ANOVA followed by a post hoc multiple
comparison (Duncan’s test) was used to analyze the diﬀer-
ences among treatments, across times, as well as between
their interactions. Categorical data were analyzed by Chi-
square test. The relationship between post-treatment BP and
theparametersforLVoraorticremodelingwasanalyzedwith
Pearson’s. P < .05 was considered statistically signiﬁcant.Evidence-Based Complementary and Alternative Medicine 3
3. Results
3.1.SystolicBlood Pressure. Body weight,heartrateandbody
temperature of the four groups remained unchanged at the
end of the study (P > .05, Figure 1). Table 1 shows the base
line and post-treatment systolic BP. There was no signiﬁcant
diﬀerence in the baseline systolic BP between the control
and the treatment groups (P > .05). The average baseline
systolic BP in the SHR-WAB and the captopril group was
slightly higher than in the SHR-350Hz group but this did
not reach statistical signiﬁcance (P > .05). In the control
group, BP gradually elevated during the 8-week study period
(P < .01). There was a signiﬁcant reduction in systolic BP
in the captopril group following the treatment (P < .01).
There was no signiﬁcant diﬀerence in the mean systolic BP
between Week 3, 6 and 8 in this group (P > .05). In the SHR-
350Hz group, the mean systolic BP at Week 3 was lower
than the baseline value (P < .05), but the mean systolic BP
in Week 6 and 8 was similar to the baseline (P > .05) and
higher than in Week 3 (P < .05). In the SHR-WAB group,
there was no signiﬁcant reduction in BP at the end of the
8-week treatment (P > .05). In the captopril and the two
electro-acupuncture groups, the mean systolic BP at the end
oftreatmentwaslowerthaninthecontrolgroup(P <.01and
P < .05, resp.).
3.2. Left Ventricular Hypertrophy. Cardiac hypertrophy was
estimated on the basis of the left ventricle/heart ratio and
the heart/body ratio. As shown in Table 2, there was no
signiﬁcant diﬀerence in the heart/body ratio, or the left ven-
tricle/heartratioamongthefourgroupsbeforethetreatment
(P > .05). In the captopril group, there was a signiﬁcant
decrease in the heart/body ratio and left ventricle/heart
ratio following the treatment (P < .05). There was also a
signiﬁcant reduction in the left ventricle/heart ratio in the
SHR-350Hz group (P < .05). The left ventricle/heart ratio in
the SHR-WAB group remained unchanged at the end of the
experiment (P > .05). There was no signiﬁcant correlation
between the Week-8 systolic BP and the left ventricle/heart
or heart/body ratio in the four groups (P > .05).
3.3. Thickness of Aorta. Morphological data obtained from
sections of the aorta are shown in Table 3. Compared with
the control group, the media thickness of the aorta, the
media-to-lumen diameter ratio, and the media area were
signiﬁcantlylowerin thethreetreatmentgroups(P <.05and
.01, resp.). The media thickness, media-to-lumen diameter
ratio, and the area of the media in the captopril group were
similar to those in the SHR-350Hz group (P > .05). There
was no signiﬁcant correlation between the Week-8 BP and
media thickness, the media-to-lumen diameter ratio, or the
media area in the four groups (P > .05).
3.4. NO. The baseline and post-treatment plasma and
myocardial NO are shown in Table 4. There was no signif-
icant diﬀerence in the plasma or myocardial NO between
the four groups before the treatment (P > .05). Following
the treatment, the plasma NO levels were elevated in the
captopril and the two acupuncture groups (P < .01 resp.).
The mean plasma NO in the three treatment groups was
higher than in the control group (P < .05 and .01, resp.).
The myocardial NO in the captopril and the SHR-350Hz
group was also elevated following the treatment (P < .05),
but the increase in the myocardial NO in the SHR-WAB
group did not reach statistical signiﬁcance (P > .05). The
post-treatmentmyocardialNOinthecaptoprilandtheSHR-
350Hz group was higher than in the control group (P < .05).
4. Discussion
The main ﬁndings of our study are: (i) Pulse width modula-
tion electro-acupuncture prevented the progressive increase
in systolic BP in SHR; (ii) The electro-acupuncture was also
associated with a reduction in the thickness of the aortic
wall, and 350Hz electro-acupuncture was associated with a
reduction in left ventricle/heart ratio; (iii) The plasma and
myocardium NO levels were elevated following the electro-
acupuncture treatment.
The meridian theory, which deals with physiologic
regulation and pathologic changes in the human body, is an
important component of traditional Chinese medicine. The
theory provides an essential guide for diagnosis and treat-
ment strategies in oriental medicine, in which acupuncture
remains as a central part [14, 15].
The stomach meridian begins from the lateral side of the
nose andascending laterallyalong the infraorbital ridge [16].
After passing through the diaphragm, it enters the stomach
and connects with the spleen and the heart. Subsequently,
it descends inside the abdomen and reaches the knees.
Eventually, it ends at the lateral side of the tip of the second
toe [16]. Based on this meridian theory, we postulate that
acupuncture on the stomach meridian would treat disorders
originatedfromstomach,spleenortheheart.“Zusanli”orST
36 has been used in several animal models to investigate the
eﬀect of acupuncture on gastrointestinal and cardiovascular
systems [17, 18]. Acupuncture on ST 36 is also known to
reduce BP [9, 19, 20], but there is a paucity of data for
studying the eﬀect of ST 36 stimulation on the remodeling
of the heart and the level of NO in the cardiac tissues.
In our study, captopril, a ﬁrst generation angiotensin-
converting enzyme inhibitor, decreased BP in the SHR.
Following the pulse width modulation electro-acupuncture,
there was no signiﬁcant reduction in the BP. However,
BP in the electro-acupuncture groups remained unchanged
after 8 weeks of the therapy, while the BP in the control
group was signiﬁcantly elevated over the same period. These
results indicate that the pulse width modulation electro-
acupuncturemayinﬂuencetheprogressionofhighBPinthis
animal model.
Previous studies have indicated that acupuncture of the
ST 36 points elevates the levels of NO in the central nervous
system or the peripheral blood [8, 9, 20]. In our study,
electro-acupuncture with 350Hz pulse width modulation or
modulation by whole audio-frequency was associated with
a signiﬁcant increase in plasma NO. Electro-acupuncture
with350Hzpulsewidthmodulationwasalsoassociatedwith4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Mean values of body weight (a), heart rate (b) and body temperature (c) before and after the experiment. There was no signiﬁcant
diﬀerence between the four time points in the four groups (P > .05). The baseline body weight, heart rate and body temperature were similar
between the four groups (P > .05).
Table 1: Eﬀect on the systolic BP.
Groups n Before Third week Sixth week Eighth week
Control 8 173.8 ± 9.0 184.4 ± 9.3§ 187.6 ± 8.7§ 191.0 ± 9.0§
(188.6) (199.7) (201.9) (205.8)
Captopril 9 179.4 ± 8.6 164.0 ± 8.7∗∗,§ 162.5 ± 8.1∗∗,§ 166.8 ± 8.3∗∗,§
(193.6) (178.3) (175.8) (180.5)
SHR-350Hz 9 173.8 ± 8.1 167.3 ± 8.5∗ 171.6 ± 8.2∗ 173.5 ± 8.7∗
(187.1) (181.3) (185.1) (187.8)
SHR-WAB 8 178.3 ± 8.6 177.4 ± 8.2 176.3 ± 7.9 174.0 ± 8.6∗
(192.5) (190.1) (189.3) (188.2)
The numbers in the bracket represent the 95th percentile.
∗P < .05 versus control; ∗∗P < .01 versus control. §P < .01 versus baseline value.Evidence-Based Complementary and Alternative Medicine 5
Table 2: Eﬀect of treatment on the weight of the left ventricle and the heart.
Groups n Heart/body ratio (mgg−1) LV/heart ratio (mgmg−1)
Before After Before After
Control 8 3.61 ± 0.07 2.99 ± 0.09 0.82 ± 0.10 0.80 ± 0.06
Captopril 9 3.19 ± 0.06 2.71 ± 0.04∗,§ 0.84 ± 0.09 0.74 ± 0.07∗,§
SHR-350Hz 9 2.97 ± 0.09 2.84 ± 0.07 0.86 ± 0.09 0.76 ± 0.12∗,§
SHR-WAB 8 3.02 ± 0.06 2.85 ± 0.08 0.81 ± 0.10 0.78 ± 0.14
LV: left ventricle.
∗P < .05 versus control group. §P < .05 versus baseline value of the same group.
Table 3: Medial thickness of aorta and the cardiomyocyte area.
Group n MT (μm) LD (μm) MT/LD (%) Media area (mm2)
Control 8 119.8 ± 7.2 1602 ± 76.0 7.4 ± 0.6 0.67 ± 0.10
Captopril 9 94.0 ± 5.5∗∗ 1709 ± 52.3 5.5 ± 0.4∗∗ 0.56 ± 0.06∗∗
SHR-350Hz 9 102.5 ± 9.1∗ 1663 ± 74.6 6.2 ± 0.8∗∗ 0.61 ± 0.07∗
SHR-WAB 8 107.5 ± 8.0∗ 1657 ± 52.1 6.5 ± 0.7∗ 0.62 ± 0.08∗
MT: media thickness; LD: lumen diameter; MT/LD: media thickness/lumen diameter.
∗P < .05 versus control; ∗∗P < .01 versus control.
an increase in the NO levels in the cardiac tissues. These
results indicate that the eﬀect of the pulse with modulation
electro-acupuncture on BP may be related to an enhanced
biosynthesis or release of NO.
LV hypertrophy and aortic thickening are two common
pathological ﬁndings in hypertensive animals [21]. In the
present study, similar to captopril treatment, 350Hz pulse
with modulation electro-acupuncture was associated with
a lower left ventricle/heart ratio. The media area and
the media-lumen diameter ratio of the aorta in the two
electro-acupuncture groups were smaller than in the control
group. These results suggest that pulse width modulation
electro-acupuncture diminishes the remodeling of the heart
and the aorta in SHR. The signaling pathways by which
the pulse width modulation electro-acupuncture inﬂuences
cardiovascularremodelingareunclear.AlthoughintheSHR-
350Hz group there was a noticeable reduction in BP at
Week 3 of the treatment, the mean systolic BP at the end
of the experiment was similar to the baseline. There was no
signiﬁcant correlation between the Week-8 BP and the left
ventricle/heart ratio or the parameters for aortic remodeling.
BPs in the SHR-WAB group remained unchanged, and
no correlation between the Week-8 BP and remodeling
parameters was indentiﬁed. Given that hypertension is
clearly responsible for the heart and aortic remodeling in
SHR [21], and we only included eight animals in each group
in the present study, a future study in a larger number of
animalsmayberequiredtodemonstratetheimpactofhyper-
tension control on cardiovascular remodeling (Figure 2).
The increase in plasma and myocardial NO following the
electro-acupuncture treatment may also be related to the
remodeling attenuation, but this is yet to be conﬁrmed
by further investigations in a larger number of animals
(Figure 2).
A potential clinical application of the present study is
that the pulse width modulation electro-acupuncture on
Electro-acupuncture for 8 weeks
BP reduction No
Prevention of aorta and LV remodeling
Figure 2: Potential mechanisms by which electro-acupuncture
diminished aortic and LV remodeling following 8-week treatment.
Both hypertension control and enhanced biosynthesis of NO may
be involved in the prevention of aortic and LV remodeling.
ST 36 point may help to manage human hypertension.
The technique is noninvasive and each treatment session
may take 30min to complete. Clinical trials are required to
ascertain if this treatment alone could reduce BP and prevent
cardiovascular remodeling in patients with hypertension.
One of the limitations of the present study is that
a relatively low voltage of electrical stimulation (2–6V)
was used for the electro-acupuncture, because only low-
intensity electro-acupuncture produces an antihypertensive
eﬀect [22]. Musically pulsed electro-acupuncture techniques
were initially developed for human models. The application
of these techniques has not been subject to robust and
systematic validation. We also used conductive skin patches,
instead of conventional needles, for the delivery of the elec-
trical stimulation. This is largely because upholding a needle
overalongperiodtimeduringtheacupunctureistechnically
challenging. The therapeutic eﬀect of needle acupuncture
andacupuncturedeliveredthroughskinpatcheshasnotbeen6 Evidence-Based Complementary and Alternative Medicine
Table 4: NO.
Group n Plasma NO (μmoll−1) Myocardium NO (pmolg−1)
Before After Before After
Control 8 22.06 ± 4.61 21.58 ± 4.75 1.21 ± 0.20 1.19 ± 0.19
Captopril 9 21.76 ± 5.12 36.07 ± 5.28∗∗,§ 1.13 ± 0.24 1.83 ± 0.20∗,Δ
SHR-350Hz 9 23.44 ± 5.33 32.65 ± 6.43∗∗,§ 1.18 ± 0.17 1.68 ± 0.15∗,Δ
SHR-WAB 8 21.39 ± 4.86 29.53 ± 5.20∗,§ 1.26 ± 0.32 1.56 ± 0.14
∗P < .05 versus control; ∗∗P < .01 versus control. §P < .01 versus baseline of the same group. ΔP < .05 versus baseline of the same group.
fully studied, but in human subjects, electrical stimulation
via skin patch electrodes is as eﬀective as needle electro-
acupuncture in pain relief [23]. It is unclear if skin patch
electrodes and needle electrodes oﬀer the same therapeutic
eﬀects in hypertension animal models. Finally, we did not
perform follow up studies, thus, the medium- to long-term
antihypertensive eﬀects of the electro-acupuncture on ST 36
points remain to be seen.
In conclusion, pulse width modulation electro-
acupuncture on ST 36 point restrains the escalation of
hypertension in SHR. This novel treatment also diminishes
the cardiac and aortic remodeling in this animal model.
Pulse width modulation electro-acupuncture elevates
plasma NO, and with 350Hz modulation, it also stimulates
the biosynthesis of NO in the cardiac tissues.
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